CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net income	$ 127,757	$ 69,737
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	105,202	105,597
Accretion of debt premium and discount, net	(664)	(695)
Deferred financing cost amortization	1,982	1,766
Accretion of above- and below-market leases, net	(4,635)	(3,276)
Tenant inducement amortization and other	519	750
Gain on sale of real estate assets	(52,097)	(3,070)
Equity based compensation	2,385	4,113
Changes in operating assets and liabilities:
Receivables, net	10,189	9,442
Deferred charges and prepaid expenses	(9,375)	(7,140)
Other assets	119	49
Accounts payable, accrued expenses and other liabilities	(40,198)	(47,185)
Net cash provided by operating activities	141,184	130,088
Investing activities:
Improvements to and investments in real estate assets	(70,981)	(82,509)
Acquisitions of real estate assets	0	(3,144)
Proceeds from sales of real estate assets	105,668	21,636
Purchase of marketable securities	(1,036)	(4,477)
Proceeds from sale of marketable securities	1,736	5,035
Net cash provided by (used in) investing activities	35,387	(63,459)
Financing activities:
Repayment of borrowings under unsecured revolving credit facility	0	(407,000)
Proceeds from borrowings under unsecured revolving credit facility	0	407,000
Proceeds from unsecured notes	0	399,324
Repayment of borrowings under unsecured notes	0	(632,312)
Deferred financing and debt extinguishment costs	(215)	(3,718)
Net proceeds from issuances of common shares	(33)	(78)
Distributions to common stockholders	(96,874)	(89,465)
Repurchases of common shares in conjunction with equity award plans	(16,412)	(11,644)
Net cash used in financing activities	(113,534)	(337,893)
Net change in cash, cash equivalents and restricted cash	63,037	(271,264)
Cash, cash equivalents and restricted cash at beginning of period	361,530	378,692
Cash, cash equivalents and restricted cash at end of period	424,567	107,428
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	323,934	106,534
Restricted cash	100,633	894
Cash, cash equivalents and restricted cash at end of period	424,567	107,428
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $823 and $1,264	67,486	73,213
Change in accrued capital expenditures	(7,733)	(3,396)
Brixmor Operating Partnership LP
Operating activities:
Net income	127,757	69,737
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	105,202	105,597
Accretion of debt premium and discount, net	(664)	(695)
Deferred financing cost amortization	1,982	1,766
Accretion of above- and below-market leases, net	(4,635)	(3,276)
Tenant inducement amortization and other	519	750
Gain on sale of real estate assets	(52,097)	(3,070)
Equity based compensation	2,385	4,113
Changes in operating assets and liabilities:
Receivables, net	10,189	9,442
Deferred charges and prepaid expenses	(9,375)	(7,140)
Other assets	119	49
Accounts payable, accrued expenses and other liabilities	(40,198)	(47,185)
Net cash provided by operating activities	141,184	130,088
Investing activities:
Improvements to and investments in real estate assets	(70,981)	(82,509)
Acquisitions of real estate assets	0	(3,144)
Proceeds from sales of real estate assets	105,668	21,636
Purchase of marketable securities	(1,036)	(4,477)
Proceeds from sale of marketable securities	1,736	5,035
Net cash provided by (used in) investing activities	35,387	(63,459)
Financing activities:
Repayment of borrowings under unsecured revolving credit facility	0	(407,000)
Proceeds from borrowings under unsecured revolving credit facility	0	407,000
Proceeds from unsecured notes	0	399,324
Repayment of borrowings under unsecured notes	0	(632,312)
Deferred financing and debt extinguishment costs	(215)	(3,718)
Net proceeds from issuances of common shares	(33)	(78)
Partner distributions and repurchases of OP Units	(113,285)	(101,533)
Net cash used in financing activities	(113,533)	(338,317)
Net change in cash, cash equivalents and restricted cash	63,038	(271,688)
Cash, cash equivalents and restricted cash at beginning of period	360,996	378,032
Cash, cash equivalents and restricted cash at end of period	424,034	106,344
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	323,401	105,450
Restricted cash	100,633	894
Cash, cash equivalents and restricted cash at end of period	424,034	106,344
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amount capitalized of $823 and $1,264	67,486	73,213
Change in accrued capital expenditures	$ (7,733)	$ (3,396)